SMTL ID : 4lwt.1

The 1.6A Crystal Structure of Humanized Xenopus MDM2 with RO5027344

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x 20Q: (3S)-3-[(3R)-1-acetylpiperidin-3-yl]-6-chloro-3-(3-chlorobenzyl)-1,3-dihydro-2H-indol-2-one(Non-covalent)

20Q.1: 11 residues within 4Å: Chain A: L.31, L.34, G.35, I.38, M.39, Y.44, F.68, V.70, H.73, I.76, Y.77 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.31, A:I.38, A:Y.44, A:F.68, A:V.70, A:V.70 Hydrogen bonds: A:L.31 Water bridges: A:Y.44 pi-Stacking: A:H.73

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: E.72, H.73, R.74, R.75 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:H.73, A:R.74, A:R.75

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, Z. et al., Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy. Bioorg.Med.Chem. (2014)

Release Date

2014-07-16

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence